{
    "thread": {
        "uuid": "5d7acc6f31dcd30e3c3a72844cb8d62ea55a6f23",
        "url": "https://article.wn.com/view/2025/01/09/Aptose_Announces_First_AML_Patients_Dosed_with_Tuspetinib_Tr",
        "site_full": "article.wn.com",
        "site": "wn.com",
        "site_section": "https://wn.com/n.america-and-canada",
        "site_categories": [
            "media"
        ],
        "section_title": "World News - N.America &amp; Canada",
        "title": "Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial - Worldnews.com",
        "title_full": "Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial - Worldnews.com",
        "published": "2025-01-09T02:00:00.000+02:00",
        "replies_count": 0,
        "participants_count": 0,
        "site_type": "news",
        "country": "US",
        "main_image": "",
        "performance_score": 0,
        "domain_rank": 3494,
        "domain_rank_updated": "2025-01-06T23:00:00.000+02:00",
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "5d7acc6f31dcd30e3c3a72844cb8d62ea55a6f23",
    "url": "https://article.wn.com/view/2025/01/09/Aptose_Announces_First_AML_Patients_Dosed_with_Tuspetinib_Tr",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": null,
    "published": "2025-01-09T02:00:00.000+02:00",
    "title": "Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial - Worldnews.com",
    "text": "Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial read full story",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
        "Health",
        "Science and Technology",
        "Economy, Business and Finance"
    ],
    "topics": [
        "Health->cancer",
        "Health->health treatment and procedure",
        "Health->medical specialisation",
        "Science and Technology->biomedical science",
        "Science and Technology->medical research",
        "Economy, Business and Finance->healthcare industry",
        "Economy, Business and Finance->financial and economic news",
        "Economy, Business and Finance->business reporting and performance"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": null,
    "webz_reporter": false,
    "external_links": [
        "https://www.globenewswire.com/news-release/2025/01/09/3007341/35575/en/Aptose-Announces-First-AML-Patients-Dosed-with-Tuspetinib-Triplet-Frontline-Therapy-in-TUSCANY-Trial.html",
        "https://globenewswire.com/news-release/2025/01/09/3007341/35575/en/Aptose-Announces-First-AML-Patients-Dosed-with-Tuspetinib-Triplet-Frontline-Therapy-in-TUSCANY-Trial.html"
    ],
    "external_images": [],
    "entities": {
        "persons": [],
        "organizations": [],
        "locations": []
    },
    "syndication": {
        "syndicated": false,
        "syndicate_id": null,
        "first_syndicated": false
    },
    "rating": null,
    "crawled": "2025-01-10T00:33:08.962+02:00",
    "updated": "2025-01-10T00:33:08.962+02:00"
}